🐂 Not all bull runs are created equal. November’s AI picks include 5 stocks up +20% eachUnlock Stocks

Rosenblatt maintains Buy on Universal Technical Institute shares, cites CFO departure

EditorNatashya Angelica
Published 11/09/2024, 13:38
UTI
-


On Wednesday, Rosenblatt Securities sustained its optimistic stance on shares of Universal Technical Institute (NYSE:UTI), keeping a Buy rating and a $22.00 price target on the company's stock. This affirmation follows the announcement that the Chief Financial Officer (CFO) of UTI will depart to join another company. The Board of Directors (BoD) at UTI has initiated the process to find a successor for the CFO role.


The firm expressed confidence that the CFO's departure will not affect UTI's operational performance or alter the company's future prospects. The statement from Rosenblatt Securities emphasized their belief that UTI does not face any execution risk stemming from this transition. Moreover, the firm underlined that the event does not indicate any changes to the company's outlook.


Rosenblatt Securities highlighted UTI's potential, noting that the institute is at the beginning of a multi-year expansion phase. The firm anticipates that UTI will capitalize on its business optimization strategies. Additionally, UTI is expected to play a significant role in addressing the growing skills gap faced by employers across the United States.


The continuation of the Buy rating and the $22.00 price target comes as Rosenblatt Securities projects that UTI will benefit from increasing demand for skilled workers. The firm's outlook suggests a positive trajectory for UTI in the foreseeable future, as it seeks to meet the needs of a changing labor market..


In other recent news, Universal Technical Institute (UTI) has reported significant growth in its third quarter of fiscal 2024. The company's revenue increased by nearly 16% to $177.5 million, driven by a 13% rise in average undergraduate full-time active students. Net income for the quarter reached $5 million, with earnings per share of $0.09. Adjusted EBITDA also saw a substantial increase of 61% to $18.4 million.


In addition to these financial results, UTI announced the resignation of Troy Anderson, the Executive Vice President and Chief Financial Officer. Christine Kline, currently serving as Chief Accounting Officer, will step in as interim CFO while the company searches for a permanent replacement.


The company also reported on its expansion efforts, including a strategic partnership with Heartland Dental and the planned opening of a co-branded campus in Fort Myers, Florida. UTI reaffirmed its guidance for fiscal 2024, projecting continued revenue growth and margin expansion. These are part of the recent developments at UTI, indicating a robust trajectory for the company's growth and profitability.


InvestingPro Insights


Universal Technical Institute's (NYSE:UTI) growth narrative is further substantiated by key financial metrics and analyst insights. According to InvestingPro data, UTI's market capitalization stands at a robust $883.05 million, with a forward-looking P/E ratio of 32.31, indicating investor confidence in its earnings potential.


Notably, UTI's revenue has experienced a substantial increase, with a growth rate of 29.01% over the last twelve months as of Q3 2024. This aligns with Rosenblatt Securities' projection of UTI's expansion phase and its role in bridging the skills gap.


InvestingPro Tips highlight that UTI is expected to see net income growth this year, which can reassure investors about the company's profitability despite the CFO transition. Moreover, UTI's strong return over the past year, with a price total return of 90.59%, reflects its market performance and could be indicative of future growth. For those interested in deeper analysis, there are more InvestingPro Tips available, offering a comprehensive look into UTI's financial health and market position.


While UTI does not pay dividends, which might deter income-focused investors, its significant revenue growth and anticipated profitability could appeal to growth investors. The company's operational performance, as suggested by the adjusted operating income of $45.65 million over the last twelve months as of Q3 2024, supports Rosenblatt Securities' confidence in UTI's business optimization strategies and its potential to thrive in the labor market landscape.


For a more detailed perspective, including additional InvestingPro Tips, visit https://www.investing.com/pro/UTI.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.